Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06569238 · ClinicalTrials.gov registry record · NA
Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification
A NA study of Diabetes Mellitus and Diabetic Foot Ulcer, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 2
- Study locations
NCT06569238: Completed NA study of Diabetes Mellitus and Diabetic Foot Ulcer, sponsored by University of Michigan.
NCT06569238 is a NA study of Diabetes Mellitus and Diabetic Foot Ulcer that has completed, run by University of Michigan. The registered enrollment target is 44 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06569238, a NA study of Diabetes Mellitus and Diabetic Foot Ulcer, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of this study is to evaluate the role of rapid diagnosis of pathogens in treatment of infection and wound healing in diabetic foot ulcers. This research is studying the use of a new device of people to learn if metagenomic next generation sequencing (mNGS) techniques technology is a feasible tool that can be used to direct targeted antibiotic therapy in infected diabetic foot ulcers. Participant's tissue will be randomized to usual care tissue collection and cultures (standard of care) or usual care tissue collection and cultures (standard of care) plus metagenomics next generation sequencing (mNGS). The participant's will not be randomized to any treatment (i.e. antibiotic therapy).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Conventional bacterial culture
- DEVICE Rapid diagnostic group using mNGS technology
Study Locations (2)
Michigan
- University of Michigan - Ann Arbor
- University of Michigan - Ann Arbor
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2026-02-18 |
| Phase | NA |
What the finished NCT06569238 record still lists
NCT06569238 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (98% lower).
The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Conventional bacterial culture is the first listed.
NCT06569238 reports a single indexed study location in Michigan.
Frequently Asked Questions
What is clinical trial NCT06569238 about?
NCT06569238 is a clinical study titled "Diabetic Foot Ulcer (DFU) Rapid Pathogen Identification". The purpose of this study is to evaluate the role of rapid diagnosis of pathogens in treatment of infection and wound healing in diabetic foot ulcers. This research is studying the use of a new device of people to learn if metagenomic next generation sequencing (mNGS) techniques technology is a feas...
What is the current status of trial NCT06569238?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2024-09-05. Estimated completion is 2026-02-18.
What conditions does trial NCT06569238 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Diabetic Foot Ulcer, Wound.
What interventions are being tested in trial NCT06569238?
The interventions under investigation include: Conventional bacterial culture (DIAGNOSTIC_TEST), Rapid diagnostic group using mNGS technology (DEVICE).
Who is sponsoring clinical trial NCT06569238?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06569238 being conducted?
This trial has 2 study locations across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06569238's enrollment target sits among peer trials
44 159th of 208 higher than 50 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI